Welcome to our dedicated page for NUCOR SEC filings (Ticker: NUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NUCOR's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NUCOR's regulatory disclosures and financial reporting.
Director Nicholas C. Gangestad reported receiving an equity award from Nucor Corporation. He acquired 755 shares of common stock at a stated price of $0.00 per share as a grant, rather than an open-market purchase. According to the footnote, these shares are tied to restricted stock units that vest immediately but are issued in stock to him, or his estate, after his service on the board of directors ends. After this award, he directly holds 4,315 common shares.
NUCOR CORP director Patrick Dempsey received an equity award of 755 shares of Common Stock as board compensation. The transaction is coded as a grant or award acquisition at a price of $0.00 per share and is not an open-market purchase.
Following this award, Dempsey directly holds a total of 18,325 shares of Nucor common stock. According to the footnote, these shares are tied to restricted stock units that vest immediately upon grant, but the underlying shares are issuable as soon as administratively practicable after his service on the board of directors ends.
CLAYTON NORMA reported acquisition or exercise transactions in this Form 4 filing.
NUCOR CORP director Norma Clayton received a grant of 755 shares of Common Stock on June 1, 2026. The award is recorded at a price of $251.49 per share and is immediately vested. Following this grant, her direct holdings total 5,825.623 shares of Nucor common stock.
Although the shares vest immediately, the footnote explains they may not be sold or otherwise transferred until her service on the board of directors ends. This makes the grant a compensation-related equity award rather than an open-market purchase or sale.
Nucor Corp Chair and CEO Leon J. Topalian reported routine equity compensation and related tax withholding transactions in company common stock. On June 1, 2026, he received 12,028 shares of common stock as a grant and 18,429 stock options with a $251.49 exercise price, each option tied to one share.
The options are issuable upon vesting of restricted stock units that vest in three annual installments starting on June 1, 2027, with potential acceleration upon death, disability, retirement, or change in control. The filing also shows 17,715 shares withheld by Nucor at $250.00 per share to cover tax liabilities from previously reported restricted stock unit vestings in 2023, 2024, and 2025.
After these transactions, Topalian directly held 126,126.47 shares of common stock, plus 1,356.52 shares held indirectly through the Nucor Profit Sharing Plan, where his plan balance was $334,341.65 as of May 27, 2026.
Nucor Corp Executive Vice President David A. Sumoski reported equity compensation awards and related tax withholdings, not open-market trades. He received restricted stock units representing 3,528 shares of common stock, which vest in three annual installments beginning on June 1, 2027, with potential acceleration upon death, disability, retirement, or change in control. He was also granted an employee stock option for 4,607 shares of common stock at an exercise price of $251.49 per share, expiring on May 31, 2036. To cover tax liabilities from earlier restricted stock unit vestings, the company withheld a total of 6,668 shares at $250 per share. After these transactions, Sumoski directly owns 236,670.88 shares of Nucor common stock.
Nucor Corporation CFO, Treasurer and EVP John Leo Sullivan III reported routine equity compensation and related tax withholding transactions. He received a grant of 1,662 restricted stock units, each representing one share of common stock, which vest in three annual installments beginning on June 1, 2027, with possible acceleration upon death, disability, retirement, or a change in control. He also received 4,607 employee stock options with an exercise price of $251.49 per share, exercisable until May 31, 2036.
To cover income tax liabilities from prior restricted stock unit vesting, a total of 236 shares of common stock were withheld by Nucor at approximately $250.00 per share, recorded as tax-withholding dispositions rather than market sales. After these transactions, Sullivan directly holds about 5,040.62 shares of Nucor common stock plus the newly granted options.
Nucor Corporation Executive Vice President Randy J. Spicer reported routine equity compensation and related tax withholding transactions. He received an award covering 2,875 restricted stock units, each representing the right to receive one share of common stock, vesting in three annual installments starting on June 1, 2027, with possible acceleration upon death, disability, retirement, or a change in control. The company will deliver the underlying shares after vesting.
Spicer was also granted employee stock options on 2,303 shares of common stock at an exercise price of $251.49 per share, exercisable beginning on June 1, 2029 and expiring on May 31, 2036. In connection with the vesting of previously awarded restricted stock units, a total of 1,800 shares of common stock were withheld at $250.00 per share to cover associated tax liabilities. Following these transactions, he holds 18,710.252 shares of Nucor common stock directly.
NUCOR CORP Executive Vice President Kenneth Rex Query reported equity compensation and related tax withholding transactions. He received 2,875 shares tied to restricted stock units that will convert into common stock in three annual installments starting on June 1, 2027, with potential acceleration upon death, disability, retirement, or a change in control. He was also granted stock options on 2,303 shares at an exercise price of $251.49, exercisable beginning June 1, 2029 and expiring May 31, 2036. In separate F-code entries, a total of 6,438 shares of common stock were withheld at $250 per share to cover tax liabilities from prior restricted stock unit vesting events, which are not open-market sales.
Nucor Corporation Executive Vice President Benjamin M. Pickett reported routine equity compensation and related tax withholding transactions. He was awarded 1,636 restricted stock units that each represent the right to receive one share of common stock, vesting in three annual installments starting on June 1, 2027, with potential acceleration upon death, disability, retirement, or a change in control. The company also granted him an employee stock option for 1,842 shares of common stock at an exercise price of $251.49 per share, exercisable beginning on June 1, 2029 and expiring on May 31, 2036. To cover tax liabilities from the vesting of previously awarded restricted stock units, 899 shares of common stock were withheld by the issuer at approximately $250.00 per share, which is an administrative disposition rather than an open-market sale. After these transactions, Pickett holds 15,095.43 shares of common stock directly, in addition to the newly granted options and unvested restricted stock units.
NUCOR CORP Executive Vice President Daniel R. Needham reported compensation-related equity activity in company stock. He received an award of 2,875 shares of common stock tied to restricted stock units that will vest in three annual installments beginning on June 1, 2027, with potential acceleration upon death, disability, retirement or a change in control. He was also granted employee stock options on 2,303 shares of common stock with an exercise price of $251.49 per share, exercisable starting on June 1, 2029. In separate entries, a total of 6,438 shares were withheld by Nucor at a value of $250 per share to cover tax liabilities from vesting of previously awarded restricted stock units, rather than sold on the open market.